Portal de Periódicos da CAPES

The association of enteroviruses with chronic heart disease

1992; Wiley; Volume: 2; Issue: 1 Linguagem: Inglês

10.1002/rmv.1980020103

1099-1654

Peter Muir,

Celiac Disease Research and Management

Reviews in Medical VirologyVolume 2, Issue 1 p. 9-18 Forum The association of enteroviruses with chronic heart disease P. Muir, P. Muir Department of Virology, United Medical and Dental Schools of Guys' and St Thomas' Hospitals (St Thomas' Campus), Lambeth Palace Road, London SE1 7EH, UKSearch for more papers by this author P. Muir, P. Muir Department of Virology, United Medical and Dental Schools of Guys' and St Thomas' Hospitals (St Thomas' Campus), Lambeth Palace Road, London SE1 7EH, UKSearch for more papers by this author First published: March 1992 https://doi.org/10.1002/rmv.1980020103Citations: 8AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Toyoda, H., Kohara, M., Kataoaka, Y., Suganuma, T., Omata, T. and Omata, T. (1984). Complete nucleotide sequences of all three poliovirus serotype genomes. J. Mol. Bio., 174, 561–585. 2 Hogle, J. M., Chow, M. and Filman, D. J. (1985). Three-dimensional structure of poliovirus at 2–9 A resolution. Science, 229, 1358–1365. 3 Tracy, S., Chapman, N. M. and Beck, M. A. (1991). Molecular biology and pathogenesis of coxsackie B viruses. Rev. Med. Virol., 1, 145–154. 4 Grist, N. R. and Reid, D. (1988). General pathogenicity and epidemiology. in, Coxsackieviruses. A General Update, ed. by M. Bendinelli and H. Friedman, pp. 221–239. Plenum Press, New York. 5 Bowles, N. E., Sewry, C. A., Dubowitz, V. and Archard, L. C. (1987). Dermatomyositis, polymyositis and coxsackie-B-virus infection. Lancet, i, 1120–1123. 6 Yousef, G. E., Bell, E. J., Mann, G. F., Murugesan, V., Smith, D. G., McCartney, R. A. and Mowbray, J. F. (1988). Chronic enterovirus infection in patients with postviral fatigure syndrome. Lancet, i, 146–150. 7 Archard, L. C., Bowles, N. E., Behan, P. O., Bell, E. J. and Doyle, D. (1988). Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J. R. Soc. Med., 81, 326–329. 8 Gow, J. W., Behan, W. M. H., Clements, G. B., Woodall, C., Riding, M. and Behan, P. O. (1991). Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. Br. Med. J., 302, 692–696. 9 Banatvala, J. E. (1987). Insulin-dependent (juvenile-onset, type 1) diabetes mellitus. Coxsackie B viruses revisited. Prog. Med. Virol., 34, 33–54. 10 Toniolo, A., Federico, G., Basolo, F. and Onodera, T. (1988). Diabetes mellitus. in, Coxsackieviruses. A General Update, ed. by M. Bendinelli and H. Friedman, pp. 351–382. Plenum Press, New York. 11 Dorries, R. (1988). New approaches to laboratory diagnosis. in, Coxsackieviruses. A General Update, ed. by M. Bendinelli and H. Friedman, pp. 203–219. Plenum Press, New York. 12 Muir, P. and Kandolf, R., The diagnosis of enterovirus-induced heart disease. In, Viral Infections of the Heart, ed. by J. E. Banatvala. Edward Arnold, London. 13 Grist, N. R. (1977). Coxsackie virus infections of the heart. in, Recent Advances in Clinical Virology 1, ed. by A. P. Waterson, pp. 141–140. Churchill Livingstone, Edinburgh. 14 Bell, E. J., McCartney, R. A., Basquill, D. and Chaudhuri, A. K. R. (1986). μ-antibody capture ELISA for the rapid diagnosis of enterovirus infection in patients with aspetic meningitis. J. Med. Virol., 19, 213–217. 15 Day, C., Cumming, H. and Walker, J. (1989). Enterovirus-specific IgM in the diagnosis of meningitis. J. Infect., 19, 219–228. 16 Banatvala, J. E. (1983). Coxsackie B virus infection in cardiac disease. in, Recent Advances in Clinical Virology 3, ed. by A. P. Waterson, pp. 99–115. Churchill Livingstone, Edinburgh. 17 Frisk, G., Torfason, E. G. and Diderholm, H. (1984). Reverse radioimmunoassays of IgM and IgG antibodies to coxsackie B viruses in patients with acute myopericarditis. J. Med. Virol., 14, 191–200. 18 McCartney, R. A., Banatvala, J. E. and Bell, E. J. (1986). Routine use of μ-antibody-capture ELISA for the sero-logical diagnosis of coxsackie B virus infections. J. Med. Virol., 19, 205–212. 19 Muir, P., Nicholson, F., Tilzey, A. J., Signy, M., English, T. A. H. and Banatvala, J. E. (1989). Chronic relapsing pericarditis and dilated cardiomyopathy: serological evidence of persistent enterovirus infection. Lancet, i, 804–807. 20 Archard, L. C., Freeke, C., Richardson, P., Meany, B., Olsen, E., Morgan-Capner, P., Rose, M., Taylor, P., Banner, N., Yacoub, M. and Bowles, N. (1988). Persistence of enterovirus RNA in dilated cardiomyopathy: a progression from myocarditis. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 349–362. Springer-Verlag, Berlin. 21 Easton, A. J. and Eglin, R. P. (1988). The detection of coxsackievirus RNA in cardiac tissue by in situ hybridization. J. Gen. Virol., 69, 285–291. 22 Kandolf, R., Canu, A., Klingel, K. et al. (1990). Molecular studies on enteroviral heart disease. in, New Aspects of Positive Strand RNA Viruses, ed. by M. A. Brinton and F. X. Heinz, pp. 340–348. American Society of Microbiology. 23 Saiki, R. K., Gelfand, D. H., Stoffel, S. et al. (1988). Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science, 239, 487–491. 24 Jin, O., Sole, M. J., Butany, J. W., Chia, W.-K., McLaughlin, P. R., Liu, P. and Liew, C.-C. (1990). Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation, 82, 8–16. 25 Weiss, L. M., Movahed, L. A., Billingham, M. E. and Cleary, M. L. (1991). Detection of coxsackievirus B3 RNA in myocardial tissues by the polymerase chain reaction. Am. J. Pathol., 138, 497–503. 26 Goodwin, J. F. (1988). Virological, immunological and clinical features of myocarditis and dilated cardio-myopathy. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 22–25. Springer-Verlag, Berlin. 27 Codd, M. B., Sugrue, D. D., Gersch, B. J. and Melton, L. J. (1989). Epidemiology of idiopathic dilated cardiomyopathy and hypertrophic cardiomyopathy: a population based study in Olmstead County, MN, 1975–84. Circulation, 80, 564–572. 28 Abelman, W. H. (1988). Etiology, pathogenesis and pathophysiology of dilated cardiomyopathies. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 3–21. Springer-Verlag, Berlin. 29 Schaper, J., Froede, R., Buck, A. and Bleese, N. (1988). Impaired myocardial ultra-structure and cytoskeleton in cardiomyopathic human heart. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 295–302. Springer-Verlag, Berlin. 30 Cambridge, G., MacArthur, C. G. C., Waterson, A. P., Goodwin, J. F. and Oakley, C. M. (1979). Antibodies to coxsackie B viruses in primary congestive cardiomyopathy. Br. Heart J., 41, 692–696. 31 Kandolf, R., Kirschner, P., Ameis, D., Canu, A., Erdmann, E., Schultheiss, H.-P., Kemkes, B. and Hofschneider, P. H. (1988). Enteroviral heart disease: diagnosis by in situ hybridization. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 337–348. Springer-Verlag, Berlin. 32 Bowles, N. E., Rose, M. L., Taylor, P., Banner, N. R., Morgan-Capner, P., Cunningham, L., Archard, L. C. and Yacoub, M. H. (1989). End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium at transplantation and lack of immune response. Circulation, 80, 1128–1136. 33 Brandenberg, R. O. and McGoon, D. C. (1987). The pericardium. In, Cardiology Fundamentals and Practice, ed. by R. O. Brandenberg, V. Fuster, E. R. Guilliami and D. C. McGoon, pp. 1662. Year Book, Chicago. 34 Banatvala, J. E. and Muir, P. (1992). Viral pericarditis. in, Recent Advances in Pericardial. Diseases, ed. by B. Maisch, Springer-Verlag, Heidelberg (in press). 35 Wilfert, C. M., Buckley, R. H., Mohanakumar, T. et al. (1977). Persistent and fatal central-nervous-system echovirus infections in patients with agammaglobulinemia. N. Engl. J. Med., 296, 1485–1489. 36 Burrows, R. (1966). Studies on the carrier state of cattle exposed to foot and mouth disease virus. J. Hyg. (Camb), 64, 81–90. 37 Friedmann, A. and Lorch, Y. (1985). Theiler's infection: a model for multiple sclerosis. Prog. Med. Virol., 31, 43–48. 38 Schnurr, D. P. and Schmidt, N. J. (1988). Persistent infections. in, Coxsackieviruses. A General Update, ed. by M. Bendinelli and H. Friedman, pp. 181–201. Plenum Press, New York. 39 Kandolf, R., Canu, A. and Hofschneider, P. H. (1985). Coxsackie B3 virus can replicate in cultured human foetal heart cells and is inhibited by interferon. J. Mol. Cell. Cardiol, 17, 167–181. 40 Kirschner, P., Kandolf, R., Canu, A., Heim, A. and Hofschneider, P. H. (1988). Antiviral activity of human fibroblast interferon in coxsackievirus B3-infected cultured human heart cells. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 385–392. Springer-Verlag, Berlin. 41 Matsumori, A. and Kawai, C. (1982). An animal model for congestive heart failure following encephalomyo-carditis virus myocarditis in mice. Circulation, 65, 1230–1235. 42 Matsumori, A. and Kawai, C. (1982). An animal model of congestive (dilated) cardiomyopathy: dilatation and hypertrophy of the heart in the chronic stage in DBA/2 mice with myocarditis caused by encephalomyocarditis virus. Circulation, 66, 355–360. 43 Khatib, R., Chason, J. L. and Lerner, A. M. (1982). A mouse model of transmural myocardial necrosis due to coxsackievirus B4: observations over twelve months. Intervirology, 18, 197–202. 44 Reyes, M. P., Ho, K. L., Smith, F. and Lerner, A. M. (1981). A mouse model of dilated-type cardiomyopathy due to coxsackievirus B3. J. Infect. Dis., 144, 232–236. 45 Klingel, K., Hohenadl, C., Mall, G., Canu, A., Reimann, B.-Y., Raab, U., Fortmuller, U., Zell, R. and Kandolf, R., (1991). Ongoing coxsackievirus B3 induced myocarditis is associated with persistent heart muscle infection. Proc. Vllth meeting of the European study group on picomaviruses, Canterbury, United Kingdom. 46 Schnurr, D. P., Cao, Y. and Schmidt, N. J. (1984). Coxsackievirus B3 persistence and myocarditis in N: NIH(S) II nu/nu and +/nu mice. J. Gen. Virol., 65, 1197–1201. 47 Kandolf, R., Ameis, D., Kirschner, P., Canu, A. and Hofschneider, P. H. (1987). In situ detection of entero-viral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc. Natl Acad. Sci. USA, 84, 6272–6276. 48 Okada, I., Matsumori, A., Kawai, C., Yodoi, J. and Tracy, S. (1990). The viral genome in experimental murine coxsackievirus B3 myocarditis; a Northern blotting analysis. J. Mol. Cell. Cardiol., 22, 999–1008. 49 Cronin, M. E., Love, L. A., Miller, F. W., McClintock, P. R. and Plotz, P. H. (1988). The natural history of encephalomyocarditis virus-induced myositis and myocarditis in mice. Viral perrsistence demonstrated by in situ hybridization. J. Exp. Med., 168, 1639–1648. 50 Archard, L. C., Bowles, N. E., Cunningham, L. et al. (1992). Molecular probes for detection of persistent enterovirus infection of human heart and their prognostic value. Eur. Heart J. (in press). 51 Cunningham, L., Bowles, N. E., Lane, R. J. M., Dubowitz, V. and Archard, L. C. (1990). Persistence of enteroviral RNA in chronic fatigue syndrome is associated with the abnormal production of equal amounts of positive and negative strands of enteroviral RNA. J. Gen. Virol., 71, 1399–1402. 52 Werner, S., Schonke, H., Klump, W., Hofschneider, P.-H. and Kandolf, R. (1988). Generation of enterovirus group-specific antisera using bacterially synthesized coxsackievirus B3 proteins. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 125–136. Springer-Verlag, Berlin. 53 Dianzini, F., Capobianchi, X., Matteucci, D. and Bendinelli, M. (1988). The role of interferon in picoma-virus infections. in, Coxsackieviruses. A General Update, ed. by M. Bendinelli and H. Friedman, pp. 65–80. Plenum Press, New York. 54 Anderson, J. L., Carlquist, J. F. and Hammond, E. H. (1982). Deficient natural killer cell activity in patients with idiopathic dilated cardiomyopathy. Lancet, ii, 1124–1127. 55 Anderson, J. L., Fowles, R. E., Bieber, C. P. and Stinson, E. B. (1978). Idiopathic cardiomyopathy, age and suppressor cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet, ii, 1174–1177. 56 Muir, P., Singh, N. B. and Banatvala, J. E. (1990). Enterovirus-specific serum IgA antibody responses in patients with acute infections, chronic cardiac disease and insulin-dependent diabetes mellitus. J. Med. Virol., 32, 236–242. 57 Chaterjee, N. K. and Tuchowski, C. (1981). Comparison of polypeptides of group B coxsackie-viruses and polypeptide synthesis in infected cells. Arch. Virol., 70, 255–269. 58 Huber, S. A. and Lodge, P. A. (1986). Coxsackie B-3 myocarditis. Identification of different pathogenic mechanisms in DBA/2 and Balb/C mice. Am. J. Pathol., 122, 284–291. 59 Huber, S. A. and Job, L. P. (1983). Difference in cyto-lytic T cell response of BALB/c mice infected with myocarditic and non-myocarditic strains of coxsackievirus group B, type 3. Infect. Immun., 39, 1419–1427. 60 Maisch, B., Herzum, M., Izumi, T. and Nunoda, S. (1988). The importance of humoral and cellular immu-nological parameters for the pathogenesis of viral myocarditis. in, New Concepts in Viral Heart Disease, ed. by H.-P. Schultheiss, pp. 259–273. Springer-Verlag, Berlin. 61 Dunn, M. J., Bradd, S., Rose, M. L., Patel, K., Seymour, C. and Yacoub, M. H. (1989). The use of Western blotting to detect anti-heart antibodies after cardiac transplantation. In, Electrophoresis '89, ed. by R. J. Radda, pp. 418–422. Technical University, Munich. 62 Saegusa, J., Prabhakar, B. S., Essani, K., McClintock, P. R., Fukuda, Y., Ferrans, V. J. and Notkins, A. L. (1986). Monoclonal antibody to coxsakievirus B4 reacts with myocardium. J. Infect. Dis., 153, 372–373. 63 Schwimmbeck, P. L., Schultheiss, H.-P., Strauer, B. E. and Oldstone, M. B. A. (1990). Antigenic determinants shared between myosin and cardiotropic viruses: significance for virus-induced heart disease. Proc. VIIIth International Congress of Virology, Berlin, Germany. 64 Caforio, A. L. P., Stewart, J. T., Bonifacio, E., Davies, M. J., McKenna, W. J. and Bottazzo, G. F. (1992). Inappropriate major histocompatibility complex expression on cardiac tissue in dilated cardiomyopathy. Relevance for autoimmunity? J. Autoimmunol. (in press). 65 Beck, M. A., Chapman, N. M., McManus, B. M., Mullican, J. C. and Tracy, S. (1990). Secondary enterovirus infection in the murine model of myocarditis. Am. J. Pathol., 136, 669–681. 66 Okada, I., Matsumori, A., Tominaga, M., Yamada, T. and Kawai, C. (1990). An animal model of chronic myocarditis: successive infection with coxsackievirus and encephalomyocarditis virus in mice. Jpn. Circ. J., 54, 788–789. 67 Anderson, J. L., Carlquist, J. F., Lutz, J. R., DeWitt, C. W. and Hammond, E. H. (1984). HLAA, B, C and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors. Am. J. Cardiol., 53, 1326–1330. Citing Literature Volume2, Issue1March 1992Pages 9-18 ReferencesRelatedInformation